In this video, Dr. Brian G.M. Durie provides details of the CASSIOPEIA trial.

The BOTTOM LINE: The IFM’s CASSIOPEIA trial shows that the use of daratumumab, Velcade, thalidomide, and dexamethasone may be a good choice for frontline therapy.

Please subscribe to our channel!
Subscribe to International Myeloma Foundation: [ Ссылка ]

Visit our website at: [ Ссылка ]

Find us online:
Facebook: [ Ссылка ]
Google+: [ Ссылка ]
IMF on twitter: @IMFMyeloma ([ Ссылка ])
Dr. Durie on twitter: @BrianDurieMD ([ Ссылка ])

Support the IMF! [ Ссылка ]
Category
Nonprofits & Activism
License
Standard YouTube License

свернуть